Search research articles
Contact Us
Filters
Showing results (1-10 of 78) with videos related to
Page
of 8
Sort By:
Expert Opinion on Biological Therapy
|
December 18, 2007
MicroRNAs as targets for antisense-based therapeutics
Jan Stenvang, Sakari Kauppinen
Essays in Biochemistry
|
September 9, 2010
MicroRNAs, epigenetics and disease
Asli Silahtaroglu, Jan Stenvang
Current Opinion in Drug Discovery & Development
|
December 18, 2004
LNA-antisense rivals siRNA for gene silencing
Jan Stenvang Jepsen, Jesper Wengel
Biochemical Society Transactions
|
November 22, 2008
Targeting of microRNAs for therapeutics
Jan Stenvang, Morten Lindow, Sakari Kauppinen
Oligonucleotides
|
August 6, 2004
Locked nucleic acid: a potent nucleic acid analog in therapeutics and biotechnology
Jan Stenvang Jepsen, Mads D Sørensen, Jesper Wengel
Oligonucleotides
|
August 6, 2004
Downregulation of p21(WAF1/CIP1) and estrogen receptor alpha in MCF-7 cells by antisense oligonucleotides containing locked nucleic acid (LNA)
Jan Stenvang Jepsen, Henrik M Pfundheller, Anne E Lykkesfeldt
Silence
|
January 11, 2012
Inhibition of microRNA function by antimiR oligonucleotides
Jan Stenvang, Andreas Petri, Morten Lindow, et al.
BMC Cancer
|
April 18, 2015
A phase II study of weekly irinotecan in patients with locally advanced or metastatic HER2- negative breast cancer and increased copy numbers of the topoisomerase 1 (TOP1) gene: a study protocol
Iben Kümler, Eva Balslev, Jan Stenvang, et al.
Breast Cancer Research and Treatment
|
March 21, 2013
A systematic review on topoisomerase 1 inhibition in the treatment of metastatic breast cancer
Iben Kümler, Nils Brünner, Jan Stenvang, et al.
Expert Review of Proteomics
|
June 20, 2013
Proximity probing assays for simultaneous visualization of protein complexes in situ
José Manuel Afonso Moreira, Stine Buch Thorsen, Nils Brünner, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 78) with videos related to
Sort By:
Page
of 8
Expert Opinion on Biological Therapy
|
December 18, 2007
MicroRNAs as targets for antisense-based therapeutics
Jan Stenvang, Sakari Kauppinen
Essays in Biochemistry
|
September 9, 2010
MicroRNAs, epigenetics and disease
Asli Silahtaroglu, Jan Stenvang
Current Opinion in Drug Discovery & Development
|
December 18, 2004
LNA-antisense rivals siRNA for gene silencing
Jan Stenvang Jepsen, Jesper Wengel
Biochemical Society Transactions
|
November 22, 2008
Targeting of microRNAs for therapeutics
Jan Stenvang, Morten Lindow, Sakari Kauppinen
Oligonucleotides
|
August 6, 2004
Locked nucleic acid: a potent nucleic acid analog in therapeutics and biotechnology
Jan Stenvang Jepsen, Mads D Sørensen, Jesper Wengel
Oligonucleotides
|
August 6, 2004
Downregulation of p21(WAF1/CIP1) and estrogen receptor alpha in MCF-7 cells by antisense oligonucleotides containing locked nucleic acid (LNA)
Jan Stenvang Jepsen, Henrik M Pfundheller, Anne E Lykkesfeldt
Silence
|
January 11, 2012
Inhibition of microRNA function by antimiR oligonucleotides
Jan Stenvang, Andreas Petri, Morten Lindow, et al.
BMC Cancer
|
April 18, 2015
A phase II study of weekly irinotecan in patients with locally advanced or metastatic HER2- negative breast cancer and increased copy numbers of the topoisomerase 1 (TOP1) gene: a study protocol
Iben Kümler, Eva Balslev, Jan Stenvang, et al.
Breast Cancer Research and Treatment
|
March 21, 2013
A systematic review on topoisomerase 1 inhibition in the treatment of metastatic breast cancer
Iben Kümler, Nils Brünner, Jan Stenvang, et al.
Expert Review of Proteomics
|
June 20, 2013
Proximity probing assays for simultaneous visualization of protein complexes in situ
José Manuel Afonso Moreira, Stine Buch Thorsen, Nils Brünner, et al.
Page
of 8